ENZO BIOCHEM INC (ENZ) Stock Price & Overview
NYSE:ENZ • US2941001024
Current stock price
The current stock price of ENZ is 0.3138 USD. Today ENZ is down by -17.77%. In the past month the price decreased by -35.96%. In the past year, price decreased by -71.21%.
ENZ Key Statistics
- Market Cap
- 16.443M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.37
- Dividend Yield
- 31.87%
ENZ Stock Performance
ENZ Stock Chart
ENZ Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ENZ. When comparing the yearly performance of all stocks, ENZ is a bad performer in the overall market: 96.16% of all stocks are doing better.
ENZ Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ENZ. The financial health of ENZ is average, but there are quite some concerns on its profitability.
ENZ Earnings
On March 17, 2025 ENZ reported an EPS of -0.04 and a revenue of 6.40M.
ENZ Forecast & Estimates
ENZ Groups
Sector & Classification
ENZ Financial Highlights
Over the last trailing twelve months ENZ reported a non-GAAP Earnings per Share(EPS) of -0.37. The EPS decreased by -430.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.57% | ||
| ROE | -45.72% | ||
| Debt/Equity | 0 |
ENZ Ownership
ENZ Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 9.66 | 90.556B | ||
| CI | THE CIGNA GROUP | 8.39 | 71.737B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 102.42 | 27.463B | ||
| LH | LABCORP HOLDINGS INC | 14.46 | 22.115B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.2 | 21.771B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.556B | ||
| DVA | DAVITA INC | 10.92 | 10.472B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 30.52 | 8.239B | ||
| CHE | CHEMED CORP | 15.2 | 5.122B | ||
| HIMS | HIMS & HERS HEALTH INC | 35.49 | 4.755B | ||
| RDNT | RADNET INC | 70.58 | 4.611B | ||
| OPCH | OPTION CARE HEALTH INC | 14.3 | 4.341B | ||
| BLLN | BILLIONTOONE INC CL A | 242.11 | 3.284B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ENZ
Company Profile
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company is headquartered in Farmingdale, New York and currently employs 125 full-time employees. The firm's primary business is conducted through its Life Sciences division, Enzo Life Sciences, which is focused on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of products, including antibodies, genomic probes, assays, biochemicals, and proteins. Its products are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The firm monetizes its technology primarily via sales through its global distribution network and licensing. The firm conducts its research and other product development efforts through internal research and collaborative relationships.
Company Info
IPO: 1980-06-13
ENZO BIOCHEM INC
60 Executive Blvd
Farmingdale NEW YORK 10022 US
CEO: Elazar Rabbani
Employees: 125
Phone: 15167555500
ENZO BIOCHEM INC / ENZ FAQ
What does ENZO BIOCHEM INC do?
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company is headquartered in Farmingdale, New York and currently employs 125 full-time employees. The firm's primary business is conducted through its Life Sciences division, Enzo Life Sciences, which is focused on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of products, including antibodies, genomic probes, assays, biochemicals, and proteins. Its products are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The firm monetizes its technology primarily via sales through its global distribution network and licensing. The firm conducts its research and other product development efforts through internal research and collaborative relationships.
What is the current price of ENZ stock?
The current stock price of ENZ is 0.3138 USD. The price decreased by -17.77% in the last trading session.
Does ENZ stock pay dividends?
ENZO BIOCHEM INC (ENZ) has a dividend yield of 31.87%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of ENZ stock?
ENZ has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the sector and industry classification for ENZO BIOCHEM INC?
ENZO BIOCHEM INC (ENZ) operates in the Health Care sector and the Health Care Providers & Services industry.
What is the market capitalization of ENZ stock?
ENZO BIOCHEM INC (ENZ) has a market capitalization of 16.44M USD. This makes ENZ a Nano Cap stock.
What is the next earnings date for ENZ stock?
ENZO BIOCHEM INC (ENZ) will report earnings on 2025-06-11.